Adding radiotherapy to endocrine therapy improved survival in locally advanced prostate cancer

Hajdenberg, Julio
June 2009
ACP Journal Club;6/23/2009, Vol. 150 Issue 6, p4
Academic Journal
The article discusses whether endocrine therapy plus radiotherapy can reduce disease-specific mortality. Randomized controlled trial was conducted in 47 centers in Norway, Sweden, and Denmark. Details of the trial including the methods, intervention and outcomes are discussed. It was concluded that adding radiotherapy to endocrine therapy reduced disease-specific and overall mortality in locally advanced prostate cancer.


Related Articles

  • Androgenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic review.  // BMC Cancer;2012, Vol. 12 Issue 1, p54 

    The article discusses a study which compared the combination of distinct hormone therapy modalities versus radiotherapy alone for overall survival, disease-free survival and toxicity. The study analyzed several databases including MEDLINE, EMBASE, LILACS, Cochrane databases and...

  • Prostate radiation in non-metastatic castrate refractory prostate cancer provides an interesting insight into biology of prostate cancer.  // Radiation Oncology;2012, Vol. 7 Issue 1, p43 

    The article focuses on a study on the use of prostate radiation for the treatment of non-metastatic castrate refractory prostate cancer. The study involved a review of 13 patients with prostate cancer who were initially treated with hormone monotherapy and then with prostate radiation. The study...

  • Role of Surgery in locally advanced prostate cancer. Nazim, Syed Muhammad; Abbas, Farhat // Pakistan Journal of Medical Sciences;May/Jun2015, Vol. 31 Issue 3, p710 

    A significant proportion of patients present with locally advanced prostate cancer with inherent higher risk of local recurrence and systemic relapse after initial treatment. Recent literature favors combination of radiation therapy and extended hormonal therapy for this subset of patients. The...

  • Radical Prostatectomy is a Valuable Treatment Alternative in Patients with High-Risk Prostate Cancer. Mangır, Naşide; Top, Tuncay; Tinay, İlker; Tanıdır,, Yılören; Türkeri, Levent // Journal of Urological Surgery;Sep2015, Vol. 2 Issue 3, p124 

    Objective To review the high-risk prostate cancer (PCa) patient database with special emphasis on the role of radical prostatectomy (RP) in comparison to external beam radiotherapy (EBRT). Materials and Methods A total of 102 patients with complete and long-term follow-up data were included....

  • From two-dimensional to three-dimensional conformal radiotherapy in prostate cancer: An Indian experience. Engineer, R.; Bhutani, R.; Mahantshetty, U.; Murthy, V.; Shrivastava, S. K. // Indian Journal of Cancer;Jul-Sep2010, Vol. 47 Issue 3, p332 

    BACKGROUND: Sparse data from India are available regarding the outcome of prostate cancer treatment. We report our experience in treating prostate cancer with radiotherapy (RT). MATERIALS AND METHODS: This study included 159 men with locally advanced cancer treated with RT with or without...

  • Prostate cancer treatments vary at county vs. private hospitals. PEDERSEN, AMANDA // Medical Device Daily;1/28/2010, Vol. 14 Issue 18, p1 

    The article reports on the findings of a study by researchers at Moores Cancer Center at the University of California, San Diego about a variation in the treatment of prostate cancer between county hospitals and private providers. The study, published in a January 2010 online version of...

  • The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials. Gottschalk, A R; Roach, M // British Journal of Cancer;3/8/2004, Vol. 90 Issue 5, p950 

    In 1901, Wilhelm Conrad Röntgen won the Nobel prize in Physics for his discovery of the Röntgen rays or, as he himself called them, X-rays. In 1966, Dr Charles Brenton Higgins won the Nobel Prize in Medicine for his breakthroughs concerning hormonal treatment of prostatic cancer. After 31...

  • Hormone therapy may offer little help to patients.  // Urology Times;4/1/2005, Vol. 33 Issue 4, p23 

    The article presents information on a study conducted by researchers at Fox Chase Cancer Center in Philadelphia, which reports that men with prostate cancer who receive hormone therapy prior to radiation therapy have the same recovery rates as those who forego the hormones. The researchers...

  • Radiation plus hormone therapy greatly improves survival Among men with high-risk prostate cancer.  // Biomedical Market Newsletter;11/9/2011, Vol. 21, p605 

    The article reports on a study which examines potential treatment for patients with locally advanced or high-risk prostate cancer. Findings reveal that the combination of radiation and hormone therapy can prolong the life of these patients and reduce their possibility to die from the disease. It...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics